Pharmafile Logo
Pharmafocus logo
Advanced Search

leukaemia

Showing 15 posts of 92 posts found.

spotleukaemia

Spotting Leukaemia

September 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, leukaemia, pharma, pharmaceutical

Leukaemia is a household name, but how much do we really understand about it? Not enough, says Bethany Torr, Campaigns …

Feature

FDA halts trial after first CAR T-associated patient death

September 6, 2017
Research and Development CAR T, CAR-T, Cancer, FDA, cellectis, leukaemia, patient death, pharma, pharmaceutical

French clinical-stage biopharma firm Cellectis has received an order from the FDA to halt its study of CAR T therapy …

News

Pfizer’s leukaemia drug gets opposing regulatory decisions on either side of the Atlantic

August 18, 2017
Medical Communications, Sales and Marketing Besponsa, Cancer, FDA, NICE, Pfizer, leukaemia, pharma, pharmaceutical

Pfizer has received a bittersweet bout of news as it emerges that its drug Besponsa (inotuzumab ozogamicin) has received approval …

News
joe_jimenez

Novartis CEO reasserts 2018 growth expectations, discusses Alcon and Sandoz future

July 18, 2017
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, biosimilars, biotech, healthcare, joe jimenez, leukaemia, pharma, pharmaceuticals

Novartis has reiterated its expectation of sales growth beginning in 2018, as well as a positive outlook for its Alcon …

News
acute_leukemia-all

Discovery of predictive protein signature births new leukaemia treatment hopes

April 12, 2017
Research and Development leukaemia

Researchers have discovered a protein signature which has proven to be highly predictive of leukaemia and has given rise to …

News
janssen_latest_logo_on_sign_closer

Scotland recommends Janssen’s Imbruvica for leukaemia

April 11, 2017
Manufacturing and Production, Sales and Marketing SMC, imbruvica, leukaemia

Janssen has been celebrating the news that its Imbruvica (ibrutinib) has been recommended by the Scottish Medicines Consortium (SMC) for …

News
novartis_outside_1

Novartis investigational CAR-T therapy gets FDA priority review

March 30, 2017
Sales and Marketing CTL019, FDA, Novartis, leukaemia

Novartis’ investigational chimeric antigen receptor T cell (CAR-T) therapy CTL019 (tisagenlecleucel-T) has been awarded has been awarded priority review by …

News
dna_research

Link discovered between immune system genes and leukaemia

February 6, 2017
Research and Development, Sales and Marketing Bloodwise, ICR, leukaemia

Research coming out of The Institute of Cancer Research, and funded by charity Bloodwise, has found that people who inherit …

News
innate-pharma

Phase 2 failure for Innate Pharma leukaemia drug

February 6, 2017
Research and Development, Sales and Marketing Innate Pharma, leukaemia, lirilumab

Lirilumab, Innate Pharma’s acute myeloid leukaemia (AML) treatment, has failed to meet its primary end point in a recent Phase …

News

Personalised leukaemia vaccine shows promise in new trial

December 12, 2016
Sales and Marketing leukaemia

A personalised cancer vaccine has proven to have significant efficacy in the treatment of acute myeloid leukaemia (AML), researchers at …

News
novartis_building

Novartis posts 82% remission rate in CAR T paediatric study

December 5, 2016
Research and Development, Sales and Marketing CAR T, CAR-T, Novartis, leukaemia, paediatric

Novartis has released the results of its global, paediatric study of the treatment of leukaemia in children and young adults …

News
teva_copy

Teva’s drug to replace chemotherapy in acute leukaemia

November 21, 2016
Medical Communications, Sales and Marketing Teva, chemotherapy, first line, first-line, leukaemia

Teva Pharmaceutical announced that their drug Trisenox has been given approval from the European Commission to become the first line …

News
nordicnanovector_final_logo

Nordic Nanovector to collaborate with Heidelberg Pharma to develop leukaemia treatment

October 26, 2016
Research and Development Nordic Nanovector, WILEX, heidelberg pharma, leukaemia

Nordic Nanovector has announced that they have formed a partnership with WILEX subsidiary, Heidelberg Pharma. Heidelberg Pharma specialises in the …

News

New treatment for leukaemia nullifies cancer cells

October 13, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boston, Cancer, Germany, Harvard, Mainz University, leukaemia

New research was able to demonstrate that a targeted drug-based inactivation of two chromatin regulators would interrupt the self-renewal of …

News

Gamida Cell receives Breakthrough Therapy Designation from FDA

October 12, 2016
Research and Development Breakthrough Therapy Designation, FDA, Gamida Cell, leukaemia, lymphoma

Gamida Cell have been granted a Breakthrough Therapy Designation for their NiCord drug. NiCord has already passed through Phase I …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025